1. Home
  2. OBDC vs TECH Comparison

OBDC vs TECH Comparison

Compare OBDC & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OBDC
  • TECH
  • Stock Information
  • Founded
  • OBDC 2015
  • TECH 1976
  • Country
  • OBDC United States
  • TECH United States
  • Employees
  • OBDC N/A
  • TECH N/A
  • Industry
  • OBDC Investment Managers
  • TECH Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • OBDC Finance
  • TECH Health Care
  • Exchange
  • OBDC Nasdaq
  • TECH Nasdaq
  • Market Cap
  • OBDC 7.5B
  • TECH 7.8B
  • IPO Year
  • OBDC 2019
  • TECH 1989
  • Fundamental
  • Price
  • OBDC $14.85
  • TECH $58.78
  • Analyst Decision
  • OBDC Buy
  • TECH Buy
  • Analyst Count
  • OBDC 8
  • TECH 12
  • Target Price
  • OBDC $15.50
  • TECH $70.00
  • AVG Volume (30 Days)
  • OBDC 2.8M
  • TECH 1.9M
  • Earning Date
  • OBDC 08-06-2025
  • TECH 08-06-2025
  • Dividend Yield
  • OBDC 11.39%
  • TECH 0.54%
  • EPS Growth
  • OBDC N/A
  • TECH N/A
  • EPS
  • OBDC 1.48
  • TECH 0.83
  • Revenue
  • OBDC $1,661,827,000.00
  • TECH $1,208,770,000.00
  • Revenue This Year
  • OBDC $21.06
  • TECH $7.07
  • Revenue Next Year
  • OBDC N/A
  • TECH $5.72
  • P/E Ratio
  • OBDC $10.04
  • TECH $71.53
  • Revenue Growth
  • OBDC 3.44
  • TECH 4.72
  • 52 Week Low
  • OBDC $12.11
  • TECH $46.01
  • 52 Week High
  • OBDC $15.87
  • TECH $83.62
  • Technical
  • Relative Strength Index (RSI)
  • OBDC 55.17
  • TECH 67.29
  • Support Level
  • OBDC $14.79
  • TECH $49.71
  • Resistance Level
  • OBDC $15.01
  • TECH $53.89
  • Average True Range (ATR)
  • OBDC 0.20
  • TECH 2.10
  • MACD
  • OBDC 0.01
  • TECH 0.56
  • Stochastic Oscillator
  • OBDC 62.84
  • TECH 92.65

About OBDC Blue Owl Capital Corporation

Blue Owl Capital Corp is a specialty finance company and business development company (BDC) focused on providing direct lending solutions to U.S. middle-market companies. The company seeks to generate current income and, to a lesser extent, capital appreciation by targeting investment opportunities with favorable risk-adjusted returns, including senior secured, subordinated, or mezzanine loans and equity-related instruments. Its investment strategies are intended to generate favorable returns across credit cycles with an emphasis on preserving capital.

About TECH Bio-Techne Corp

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.

Share on Social Networks: